<DOC>
	<DOCNO>NCT00839202</DOCNO>
	<brief_summary>A novel immuno-assay evaluate measurement Factor VIII . Current procedure measure rate assay subject much artefact . The hypothesis new assay give read absolute quantity FVIII provide suitable indicator FVIII content clot factor manufacturer , physician patient .</brief_summary>
	<brief_title>Activity Content Factor VIII ( FVIII ) Human Plasma : The Assessment Novel Immunoassay</brief_title>
	<detailed_description>Remnant sample collect clinical laboratory assay new procedure compare standard functional activate partial thromboplastin time ( APTT ) assay . A PK study seven study subject hemophilia A carried use five different commercially licensed factor VIII concentrate blood sample draw PK analysis measure FVIII novel assay compare standard APTT assay . The concentrate use PK study also apply two assay system determine product 's specific activity .</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>adult hemophilia A factor VIII le 2 % informed consent sign absence inhibitor history high respond inhibitor anemia</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>factor VIII</keyword>
	<keyword>hemophilia A</keyword>
	<keyword>assay</keyword>
</DOC>